WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David L. MahoneyDirector2026-08-18400$119.64
$47.86kSell
David L. MahoneyDirector2026-08-184,984$117.47
$585.48kSell
David L. MahoneyDirector2026-08-1891,167$118.24
$10.78MSell
David L. MahoneyDirector2026-08-187,055$118.88
$838.71kSell
Gary Charles RobbCXO2026-08-1710,000$116.26
$1.16MSell
Sean MaduckOfficer2026-08-143,664$114.49
$419.49kSell
James N. WilsonDirector2026-08-142,279$112.64
$256.71kSell
James N. WilsonDirector2026-08-144,668$111.44
$520.21kSell
James N. WilsonDirector2026-08-143,053$110.50
$337.34kSell
Sean MaduckOfficer2026-08-143,664$8.27
$30.30kBuy

1 of 19

CORT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright41.45%44,802,403$5.42BInsider
Bakker Juliet Tammenoms10.26%11,089,541$1.34BInsider
Longitude Venture Partners LP10.14%10,956,002$1.33BInsider
Alta Biopharma Partners II LP9.23%9,982,720$1.21BInsider
G. Leonard Baker Jr.8.73%9,440,067$1.14BInsider
Tench Coxe6.37%6,890,503$834.10MInsider
Joseph C. Cook Jr.6.26%6,765,805$819.00MInsider
David L. Anderson5.94%6,420,729$777.23MInsider
William H. Younger Jr.5.88%6,353,537$769.10MInsider
Joseph K. Belanoff5.78%6,248,596$756.39MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT0.04%99.96%Net BuyingNet Selling
EXEL0.10%5.67%Net SellingNet Selling
BMRN0.10%1.81%Net Selling
ARWR0.08%9.73%Net SellingNet Selling
HALO0.11%30.26%Net SellingNet Selling
View Top Biotech Stocks

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 0.08% institutional shareholders, 179.51% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 41.45% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $5.48B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.